Event Type
Disclosure
Voluntary
Variant
8-K
Other Events. On December 16, 2025, the Company issued a press release titled "MediBeacon® Next Generation TGFR TM System Receives FDA Approval”. A copy of the
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release dated December 16 , 2025, titled “MediBeacon® Next Generation T GFR T